- Category
- Small (2023-24)
- Udyam number
- UDYAM-AS-16-0000303

Avizen Biopharma Private Limited
About Avizen Biopharma Private Limited
Data last updated:
Avizen Biopharma Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24304AS2016PTC017532. Its GSTIN is 18AAOCA6748E1ZC (Assam). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹5.42 Cr. It is led by directors including Rajendra Kumar Verma and Mahendra Kumar Verma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sagar Bizz Plex 1st Floor S.R. Bora Lane G.S. Road Ulubari, Guwahati, Assam, India – 781007.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.61 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹32.92 Lakh (net margin 1.6%) and EBITDA of ₹1.1 Cr (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years and 68% over five years.
The company has about 16 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹6.1 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 3 cases are pending.
Avizen Biopharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-16-0000303). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Avizen Biopharma
Contact details
Avizen Biopharma Private Limited's registered office is in Guwahati, Assam. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSagar Bizz Plex 1st Floor S.R. Bora Lane G.S. Road Ulubari, Guwahati, Assam, India – 781007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Avizen Biopharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avizen Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Avizen Biopharma Private Limited, buy the company report.
Financials of Avizen Biopharma Private Limited
FY 2024 filings availableAvizen Biopharma Private Limited reported revenue of ₹20.61 Cr (up 272% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 68% over five years, including 272% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.1 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avizen Biopharma Private Limited, buy the company report.
Board of directors of Avizen Biopharma Private Limited
Avizen Biopharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Kumar Verma Also directs: VL Infratech Services Private Limited, Agram Pharmaceuticals LLP, Astam Lifesciences Private Limited and 1 more | Director | 09 Aug 2016 | 10 Years 3 Months | Current |
| Mahendra Kumar Verma Also directs: VL Infratech Services Private Limited | Director | 09 Aug 2016 | 10 Years 3 Months | Current |
| Sunil Kumar Khemani | Director | 25 Feb 2017 | 9 Years 8 Months | Current |
| Alka Verma | Director | 17 Jul 2025 | 1 Years 4 Months | Current |
Peer comparison
Avizen Biopharma Private Limited is compared with the 4 companies closest to it by revenue in the Biotechnology industry (Biopharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aspen Biopharma Labs Private Limited | ₹33.52 Cr (FY 2022) | 161.0% | Hyderabad, Telangana, India | |||
| Wembrace Biopharma Private Limited | ₹30.3 Cr (FY 2025) | -10.0% | New Delhi, Delhi, India | |||
| Avizen Biopharma Private Limitedthis company | ₹20.61 Cr (FY 2025) | ₹32.92 Lakh | 1.6% | 272.0% | 16 | Guwahati, Assam, India |
| Escientia Biopharma Private Limited | ₹20.04 Cr (FY 2025) | -79.0% | Hyderabad, Telangana, India | |||
| Cennet Biopharma Private Limited | ₹18.59 Cr (FY 2024) | 27.0% | Delhi, India |
To see the full peer comparison of Avizen Biopharma Private Limited, buy the company report.
Auditor
Avizen Biopharma Private Limited is audited by Hari Singh & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Hari Singh & Associates | FY 2024 | 323509E |
Shareholding
The shareholding of Avizen Biopharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avizen Biopharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 2021 | 100516420 | Others | ₹18.5 Lakh | Open | |
| 29 Sep 2020 | 100397271 | Others | ₹36.8 Lakh | Open | |
| 30 Mar 2017 | 100094089 | Others | ₹5.55 Cr | Open |
To see the full charge records of Avizen Biopharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Avizen Biopharma Private Limited has 5 court cases on record: 2 filed by Avizen Biopharma, 3 filed against it. 3 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 1 |
| High courts | 2 | 2 | 2 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed against the company by Franco-Indian Remedies Private Limited and 3 others | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Franco-Indian Remedies Private Limited | Pending |
| District court, Kamrup Metro, Assam | Court case (N I Act) | Filed by the company against M/S Cobless Healthcare Pvt. Ltd. and 2 others | Disposed |
| District court, Kamrup Metro, Assam | Court case (Complaint Case C.R.) | Filed by the company against M/S Novita Healthcare Pvt. Ltd. and 2 others | Disposed |
| District court, Kamrup Metro, Assam | Court case (Motor Vehicle Act) | Filed against the company by State of Assam | Pending |
To see the full case history of Avizen Biopharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Avizen Biopharma Private Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 173 overdue payments to 38 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 38)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Parkash Industries | |||
| Mahima Lifesciences Private Limited | |||
| Yurvie Packaging Pvt Ltd | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Avizen Biopharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Avizen Biopharma Private Limited has a workforce of 16 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 16 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Avizen Biopharma Private Limited, buy the company report.
GST
Avizen Biopharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAOCA6748E1ZC | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avizen Biopharma Private Limited, buy the company report.
Recent activity
Avizen Biopharma Private Limited has 9 board changes on record since 2016: 4 appointments and 5 cessations. The latest: Alka Verma ceased to be Additional Director on 29 Sep 2025.
4 earlier events are in the company report.
Frequently asked questions
Avizen Biopharma is an active private limited company based in Guwahati, Assam, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 August 2016 (10+ years old) and is registered under CIN U24304AS2016PTC017532.
Avizen Biopharma has 4 current directors:
- Rajendra Kumar Verma - Director
- Mahendra Kumar Verma - Director
- Sunil Kumar Khemani - Director
- Alka Verma - Director
The latest financial statements of Avizen Biopharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Avizen Biopharma is 18AAOCA6748E1ZC, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Avizen Biopharma is U24304AS2016PTC017532. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avizen Biopharma has 5 court cases on record: 2 filed by the company and 3 filed against it. 3 are pending. Most are in the district courts.
Avizen Biopharma was incorporated on 09 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Avizen Biopharma by revenue are Aspen Biopharma Labs Private Limited, Wembrace Biopharma Private Limited, Escientia Biopharma Private Limited, Cennet Biopharma Private Limited, all in the Biotechnology industry (Biopharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Alka Verma ceased to be Additional Director on 29 Sep 2025. Subhkaran Verma ceased to be Additional Director on 19 Jul 2025. Alka Verma was appointed as Director on 17 Jul 2025. Avizen Biopharma has 9 board changes on record in total.
Yes, Avizen Biopharma is registered as a small enterprise under Udyam registration (number: UDYAM-AS-16-0000303).
Avizen Biopharma has 7 MSME Form 1 returns on record between 2019 and 2022, listing 173 overdue payments to 38 micro and small suppliers. The latest return was filed on 30 Jun 2022.
The registered office of Avizen Biopharma is at Sagar Bizz Plex 1st Floor S.R. Bora Lane G.S. Road Ulubari, Guwahati, Assam, India – 781007.

